Entrapment of the Common Peroneal Nerve due to Multiple Hereditary Exostoses with Synostosis of the Proximal Tibiofibular Joint
Journal Title: Journal of Musculoskeletal Disorders and Treatment - Year 2017, Vol 3, Issue 2
Abstract
A 37-year-old male presented with progredient weakness of dorsiflexion in his left ankle since 5 months that was accompanied with sensory deficits in the superficial peroneal nerve area at the dorsal aspect of his left foot. Additionally, the patient reported increasing pain around his left Proximal Tibiofibular Joint (PTFJ). There was a history of known Multiple Hereditary Exostoses (MHE) that was primarily diagnosed with patient's age of 8 years.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP348103
- DOI 10.23937/2572-3243.1510033
- Views 121
- Downloads 0
Deep Venous Thrombosis in Behcet's Syndrome: is Anticoagulation Necessary?
Deep vein thrombosis (DVT) in the lower extremities is a common medical presentation. Anticoagulation is the cornerstone of management. However, not all DVTs require anticoagulation. We report a case of DVT in a patient...
Improved Walking Capabilities after Eight Weeks of Hal® Exoskeleton-Supported Treadmill Therapy in a Patient with Limb-Girdle Muscular Dystrophy Type 2I
Objective:HAL® robot suit is a new voluntary driven exoskeleton for the lower limbs. It has already been demonstrated to improve walking functions in spinal cord injury and stroke patients. So far, it is not known if HAL...
Intramedullary Gas not Related to Infection
The presence of gas in joints or soft tissues is usually indicative of infectious pathology or degenerative diseases [1]. However, the presence of gas inside the medullary canal in the diaphysis of long bones is an uncom...
Developmental Insights into Osteoarthritis Increase the Applicability of New Animal Models
Osteoarthritis (OA) is an increasingly common degenerative joint condition, estimated to affect more than 100 million people worldwide and more than 40% of people over 70 years of age. There is currently no pharmacologic...
Necrotizing Fasciitis without Inflammatory Signs in Patients Receiving Anti-Interleukin-6 Receptor Antibody (Tocilizumab): Two Cases Report
Tocilizumab is a monoclonal antibody directed against the interleukin-6 receptor and used for the treatment of rheumatoid arthritis (RA). However, patients treated with tocilizumab have risk of infection, such as necroti...